Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Biochem Pharmacol. 2013 Mar 13;85(10):1495–1503. doi: 10.1016/j.bcp.2013.02.039

Fig. 6.

Fig. 6

Inhibition of the Kir6.1/SUR2B currents by PPARβ/δ agonists. GW0742 (A) and GW501516 (B) are almost identical in their structures. They both inhibited the Kir6.1/SUR2B currents moderately. The IC50 was 80 μmol L-1 for GW0742 and 100μmol L-1 for GW501516, respectively (C).